Sign in Start Free

CompanyHealthtech & BiotechEurope

Novo Nordisk

Quiet

Global pharma leader in diabetes and obesity treatments including Ozempic/Wegovy

Add to Watchlist

Company Overview

Sectors

PharmaMetabolic Disease

Peer Comparison

10

5

Samsung Biologics

3

3

1

1

1

1

0

Terumo Corporation

0

#9of 10 in industry

Signal Timeline

1 total

Date unknown

PartnershipCanonical—

Novo Nordisk to Sell Weight-Loss Drugs Ozempic and Wegovy Through Hims & Hers Platform

Novo Nordisk has partnered with Hims & Hers to make its popular weight-loss drugs, Ozempic and Wegovy, available through the telehealth platform.

Get Novo Nordisk signal updates

Get notified when new signals are published for this company.

Explore More Industries

AI & Frontier Intelligence307 signals Fintech & Digital Finance168 signals Mobility, EV & Autonomous Systems163 signals Energy, Climate & Industrial Transition165 signals